Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine G-CSF in Recurrent Implantation Failure
NCT03783208Completed
- Sponsor
- Gürgan Clinic
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised trial of filgrastim in Recurrent Implantation Failure (RIF) (2 arms), sponsored by Gürgan Clinic. Primary endpoint: Clinical pregnancy rate at 1 month. Started Nov 2018; status: completed.
02
Drugs
filgrastim
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03783208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783208.